The National Institute of Allergy and Infectious Diseases (NIAID)-funded researchers who developed a genetically modified mosquito-killing fungus, a weapon made from spider toxin, that destroys blood-sucking enemies from the inside and helps save people from disease and death.
Mosquitoes that landed on surfaces coated with the antimalarial compound atovaquone were completely blocked from developing Plasmodium falciparum (P. falciparum), the parasite that causes malaria, according to new research led by Harvard T.H. Chan School of Public Health.
Sierra Leone has achieved vast declines in malaria deaths between 2010 and 2015, the highest in Western Africa. This is linked to a range of interventions, including increased availability of diagnostic tests, free treatments and mass distribution of insecticide treated nets (ITNs).
One of the world’s oldest and deadliest diseases — remains a critically important public health and biomedical research challenge. Despite remarkable advances in reducing malaria incidence and deaths since 2000, recent progress has become stagnant and has even reversed in some regions.
The National Institute of Allergy and Infectious Diseases (NIAID) in the United States is supporting the development of products to control mosquitoes without the limitations of traditional chemical pesticides.
National Institute of Allergy and Infectious Diseases (NIAID) scientists are developing promising dengue virus vaccine candidates, with the goal of creating a vaccine that is protective against all four dengue virus serotypes. Preclinical and early phase clinical testing has been… Read More ›
Zika virus infection among pregnant women can lead to developmental problems in fetuses and newborns.